Results 81 to 90 of about 6,474 (125)

Treatment With Valoctocogene Roxaparvovec in a Patient With Severe Hemophilia A Led to Sustained Normal FVIII Levels. [PDF]

open access: yesHaemophilia
Herbst K   +8 more
europepmc   +1 more source

First-in-human study of TN-201, an AAV9 gene replacement therapy in MYBPC3-associated hypertrophic cardiomyopathy: initial safety, pharmacodynamic, and imaging results from MyPEAK-1. [PDF]

open access: yesCardiovasc Res
Desai MY   +17 more
europepmc   +1 more source

CRISPR-Cpf1-Mediated Gene-Editing System Based on a Single Bidirectional Promoter. [PDF]

open access: yesInt J Mol Sci
Kim S   +6 more
europepmc   +1 more source

Exploration of genes and identification of evolutionary evidence in adeno-associated viruses. [PDF]

open access: yesJ Microbiol
Lee C   +10 more
europepmc   +1 more source

Final Analysis of the Phase 1/2 Trial of Valoctocogene Roxaparvovec for Severe Haemophilia A. [PDF]

open access: yesHaemophilia
Raheja P   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy